Erythrocyte membrane phosphatidylserine exposure in obesity

Obesity

Volumn 17, Issue 2, 2009, Pages 318-322

  Solá, Eva ^a,b   Vayá, Amparo ^c   Martínez, Marcial ^c   Moscardó, Antonio ^c   Corella, Dolores ^b   Santaolaria, Maria Luisa ^c   Espãa, Francisco ^c   Hernández Mijares, Antonio ^a,b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE; PEPTIDE FRAGMENT; PHOSPHATIDYLSERINE; PROTEIN PRECURSOR; PROTHROMBIN; PROTHROMBIN FRAGMENT 1; PROTHROMBIN FRAGMENT 2;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PHYSIOLOGY; WEIGHT REDUCTION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHOSPHATIDYLSERINES; PROTEIN PRECURSORS; PROTHROMBIN; WEIGHT LOSS; YOUNG ADULT;

EID: 58849167628     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.499     Document Type: Article

References (35)

1. Janssen I. Morbidity and mortality risk associated with an overweight BMI in older men and women. Obesity (Silver Spring) 2007;15:2019-2026.
2. Freeza EE, Wachtel MS. A simple venous thromboembolism prophylaxis protocol for patients undergoing bariatric surgery. Obesity (Silver Spring) 2006;14:1961-1965.
3. Brun JF, Aloulou I, Varlet-Marie E. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia? Clin Hemorheol Microcirc 2004;30:203-209.
4. Solá E, Vayá A, Corella D et al. Erythrocyte hyperaggregation in obesity: determining factors and weight loss influence. Obesity (Silver Spring) 2007;15:2128-2134.
5. Valensi P, Paries J, Maheo P, Gaudey F, Attali JR. Erythrocyte rheological changes in obese patients: influence of hyperinsulinism. Int J Obes Relat Metab Disord 1996;20:814-819.
6. Lowe G, Rumley A, Norrie J et al. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb Haemost 2000;84:553-558.
7. Solerte SB, Fioravanti M, Pezza N et al. Hyperviscosity and microproteinuria in central obesity: relevance to cardiovascular risk. Int J Obes Relat Metab Disord 1997;21:417-423.
8. Perez-Martin A, Dumortier M, Pierrisnard E et al. Multivariate analysis of relationships between insulin sensitivity and blood rheology: is plasma viscosity a marker of insulin resistance? Clin Hemorheol Microcirc 2001;25:91-103.
9. Samocha-Bonet D, Lichtenberg D, Tomer A et al. Enhanced erythrocyte adhesiveness/aggregation in obesity corresponds to low-grade inflammation. Obes Res 2003;11:403-407.
10. Le Devehat C, Khodabandehlou T, Dougny M. Hemorheological parameters in isolated obesity. Diabete Metab 1992;18:43-47.
11. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997;89:1121-1132.
12. Schroit AJ, Zwaal RF. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta 1991;1071: 313-329.
13. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005;62:971-988.
14. Lang KS, Roll B, Myssina S et al. Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell Physiol Biochem 2002;12:365-372.
15. Elizondo A, Araya J, Rodrigo R et al. Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients. Obesity (Silver Spring) 2007;15:24-31.
16. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, Desouza CA. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity (Silver Spring) 2006;14:2127-2131.
17. Steffes MW, Gross MD, Lee DH, Schreiner PJ, Jacobs DR Jr. Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the oronary Artery Risk Development in Young Adults Study. Obesity (Silver Spring) 2006;14:319-326.
18. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341-390.
19. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005;28:S37-S42.
20. ICSH (International Commitee for Standarization in Haematology. Expert Panel on Blood Rheology). Guidelines for measurement of blood viscosity and erythrocyte deformability. Clin Hemorheol 1986;6:439.
21. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
22. Schmid-Schönbein H, Volger E, Teitel P et al. New hemorrheological techniques for the routine laboratory. Clin Hemorrheol 1983;2:93-105.
23. Chabanel A, Samama M. Evaluation of a method to assess red blood cell aggregation. Biorheology 1989;26:785-797.
24. Ruef P, Pöschl JMB, Linderkamp O. The Rheodyn SSD for measuring erythrocyte deformability. Biorheology 1995;32:357-358.
25. Ercan M, Konukoglu D, Erdem Yesim T. Association of plasma viscosity with cardiovascular risk factors in obesity: an old marker, a new insight. Clin Hemorheol Microcirc 2006;35:441-446.
26. Aloulou I, Varlet-Marie E, Mercier J, Brun JF. The hemorheological aspects of the metabolic syndrome are a combination of separate effects of insulin resistance, hyperinsulinemia and adiposity. Clin Hemorheol Microcirc 2006;35:113-119.
27. Setty BN, Kulkarni S, Stuart MJ. Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood 2002;99:1564-1571.
28. Atichartakarn V, Angchaisuksiri P, Aryurachai K et al. Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta-thalassaemic patients. Br J Haematol 2002;118:893-398.
29. de Jong K, Geldwerth D, Kuypers FA. Oxidative damage does not alter membrane phospholipid asymmetry in human erythrocytes. Biochemistry 1997;36:6768-6776.
30. Avellone G, Di Garbo V, Cordova R et al. Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution. Thromb Res 1994;75:223-231.
31. Conlan MG, Folsom AR, Finch A et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993;70:380-385.
32. Raz O, Rogowski O, Shapira I et al. Dissociated effects of physical activity and weight loss on fibrinogen concentrations and markers of red blood cell aggregation. Relevance for life style modification in atherothrombosis. Clin Hemorheol Microcirc 2007;37:253-262.
33. Cogan U, Schachter D. Asymmetry of lipid dynamics in human erythrocyte membranes studied with impermeant fluorophores. Biochemistry 1981;20:6396-6403.
34. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128.
35. Dandona P, Mohanty P, Ghanim H et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 2001;86:355-362.